L
47
-5
GRMN
68
-2
NI
60
2
COF
57
-2
FRT
36
2
PDCO
38
2
DFS
56
-4
STX
52
2
VNO
51
-9
HBI
50
-2
SPG
55
9
NUE
48
-2
BRK.B
33
-3
WY
56
3
AXP
60
-3
JWN
52
2
APD
47
-2
GLW
48
-4
LEG
28
6
NKE
28
-2
L
47
-5
GRMN
68
-2
NI
60
2
COF
57
-2
FRT
36
2
PDCO
38
2
DFS
56
-4
STX
52
2
VNO
51
-9
HBI
50
-2
SPG
55
9
NUE
48
-2
BRK.B
33
-3
WY
56
3
AXP
60
-3
JWN
52
2
APD
47
-2
GLW
48
-4
LEG
28
6
NKE
28
-2
Financhill
Back

Nanosphere Health Sciences 10K Form

Sell
41

NSHS.CX
Nanosphere Health Sciences

Last Price:
0.0450
Seasonality Move:
-0.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NSHS.CX News And Ratings

See the #1 stock for the next 7 days that we like better than NSHS.CX

NSHS.CX Financial Statistics

Sales & Book Value

Annual Sales: $289.31K
Cash Flow: $25.1K
Price / Cash Flow: 0
Annual Sales: $-0.22
Price / Book: 0

Profitability

EPS (TTM): -0.02450
Net Income (TTM): $-269.7K
Gross Margin: $20K
Return on Equity: 0%
Return on Assets: 0%

Nanosphere Health Sciences Earnings Forecast

Key Nanosphere Health Sciences Financial Ratios

  • The Gross Profit Margin over the past 7 years for NSHS.CX is 40.73%.
  • The Selling, General & Administrative Expenses for NSHS.CX have been equal to 1,020.23% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 11 years.

Nanosphere Health Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: CNSX
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NSHS.CX
Website: nanospherehealth.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NSHS.CX Technical Analysis vs Fundamental Analysis

Sell
41
Nanosphere Health Sciences (NSHS.CX) is a Sell

Is Nanosphere Health Sciences a Buy or a Sell?